Weight Loss Warnings: The Dark Side of Wegovy's Success The success story of Wegovy, a popular weight loss medication, has been met with growing concern as researchers link it to a rare and potentially debilitating condition called ischemic optic neuropathy (ION).
ION can cause sudden blindness. While the risks may be small, the implications are significant, especially in an era where GLP 1 medications are increasingly being prescribed for conditions beyond obesity treatment.
A study published in the British Journal of Ophthalmology analyzed millions of adverse event reports submitted to the FDA between 2017 and 2024.